Related Experiment Video
Updated: May 7, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Late-onset Sheehan's syndrome presenting with rhabdomyolysis and hyponatremia: a case report
Maurizio Soresi1, Giuseppe Brunori, Roberto Citarrella
1Internal Medicine Unit, Biomedical Department of Internal Medicine and Subspecialties (DIBIMIS), University of Palermo, Palermo, Italy. lydiagiannitp@gmail.com.
Introduction:
Hyponatremia associated with rhabdomyolysis is a rare event and a correct diagnostic approach is required to rule out this or other diseases as a primary cause and to avoid other complications resulting from a lack of appropriate treatment.
Case Presentation:
A 64-year-old Caucasian woman presented to our facility with worsening fatigue, slurred speech, nausea and vomiting, and high serum levels of creatine kinase and myoglobin together with hyponatremia. Normal arterial blood gas analysis results, normal serum potassium levels, increased urine sodium levels, urine specific gravity of >1003N/m3 and low urine volume suggested an endocrine etiology. Her low cortisol and thyroid hormone serum levels suggested a pituitary disorder. A magnetic resonance imaging study showed atrophy of her pituitary gland. A more detailed study of our patient's obstetric history revealed a post-partum hemorrhage 30 years earlier. She was diagnosed as having late-onset Sheehan's syndrome and treated with hormone replacement therapy, which normalized her clinical picture.
Conclusions:
This case report shows that, in hyponatremia-associated rhabdomyolysis, an endocrinological origin should always be considered. This should include Sheehan's syndrome as it can occur with late onset.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Hyperosmolar Hyperglycemic State
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Hepatic Encephalopathy
Chronic Kidney Disease II: Clinical Manifestations